Simultaneously, macropinocytosis of the protamine nanomedicine by the targeted cells will lead to the intracellular delivery of intact siRNA to silence ALK oncogenes and inhibit lymphoma cell proliferation. The gene discussed is ALK; the disease is lymphoma.